186 related articles for article (PubMed ID: 32599983)
21. ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.
Lin L; Li X; Pan C; Lin W; Shao R; Liu Y; Zhang J; Luo Y; Qian K; Shi M; Bin J; Liao Y; Liao W
Cell Death Dis; 2019 Feb; 10(3):173. PubMed ID: 30787271
[TBL] [Abstract][Full Text] [Related]
22. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving SRC Signaling in Gastric Cancer.
Zhang X; Soutto M; Chen Z; Bhat N; Zhu S; Eissmann MF; Ernst M; Lu H; Peng D; Xu Z; El-Rifai W
Gastroenterology; 2022 Sep; 163(3):620-636.e9. PubMed ID: 35588797
[TBL] [Abstract][Full Text] [Related]
23. FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors.
Ezzat S; Wang R; Pintilie M; Asa SL
Oncotarget; 2017 Jan; 8(2):3481-3494. PubMed ID: 27966451
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Efficacy of Postoperative Chemotherapy by DNA Methylation of CDO1 in Gastric Cancer.
Harada H; Soeno T; Yokoi K; Nishizawa N; Ushiku H; Hosoda K; Hiki N; Yamashita K
J Surg Res; 2020 Dec; 256():404-412. PubMed ID: 32777557
[TBL] [Abstract][Full Text] [Related]
25. FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.
Dutra RL; de Carvalho MB; Dos Santos M; Mercante AM; Gazito D; de Cicco R; Group G; Tajara EH; Louro ID; da Silva AM
PLoS One; 2012; 7(11):e50747. PubMed ID: 23226373
[TBL] [Abstract][Full Text] [Related]
26. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
[TBL] [Abstract][Full Text] [Related]
27. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.
Sahadevan K; Darby S; Leung HY; Mathers ME; Robson CN; Gnanapragasam VJ
J Pathol; 2007 Sep; 213(1):82-90. PubMed ID: 17607666
[TBL] [Abstract][Full Text] [Related]
28. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension.
Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS
Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A
J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4.
Yu T; Wang LN; Li W; Zuo QF; Li MM; Zou QM; Xiao B
Cancer Sci; 2018 May; 109(5):1393-1403. PubMed ID: 29569792
[TBL] [Abstract][Full Text] [Related]
31. Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors.
Cros J; Moati E; Raffenne J; Hentic O; Svrcek M; de Mestier L; Sbidian E; Guedj N; Bedossa P; Paradis V; Sauvanet A; Panis Y; Ruszniewski P; Couvelard A; Hammel P
Neuroendocrinology; 2016; 103(5):495-9. PubMed ID: 26335532
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer.
Sasaki H; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Oncol Rep; 2008 Nov; 20(5):1125-30. PubMed ID: 18949411
[TBL] [Abstract][Full Text] [Related]
33. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer.
Jiang Z; Wang X; Li J; Yang H; Lin X
J Cell Mol Med; 2018 Sep; 22(9):4377-4386. PubMed ID: 29992789
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
[TBL] [Abstract][Full Text] [Related]
35. FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer.
Peláez-García A; Barderas R; Torres S; Hernández-Varas P; Teixidó J; Bonilla F; de Herreros AG; Casal JI
PLoS One; 2013; 8(5):e63695. PubMed ID: 23696849
[TBL] [Abstract][Full Text] [Related]
36. Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.
Streit S; Bange J; Fichtner A; Ihrler S; Issing W; Ullrich A
Int J Cancer; 2004 Aug; 111(2):213-7. PubMed ID: 15197773
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA LINC00165-induced by STAT3 exerts oncogenic properties via interaction with Polycomb Repressive Complex 2 to promote EMT in gastric cancer.
Jin Y; Wu P; Zhao W; Wang X; Yang J; Huo X; Chen J; De W; Yang F
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):223-230. PubMed ID: 30448060
[TBL] [Abstract][Full Text] [Related]
38. FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.
Marmé F; Werft W; Benner A; Burwinkel B; Sinn P; Sohn C; Lichter P; Hahn M; Schneeweiss A
Ann Oncol; 2010 Aug; 21(8):1636-1642. PubMed ID: 20147743
[TBL] [Abstract][Full Text] [Related]
39. Role of fibroblast growth factor 4 in the growth and metastasis of colorectal cancer.
Ye Y; Jiang D; Li J; Han C; Wang X; Wang F; Li J
Int J Oncol; 2020 Jun; 56(6):1565-1573. PubMed ID: 32236572
[TBL] [Abstract][Full Text] [Related]
40. Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma.
Xin Z; Song X; Jiang B; Gongsun X; Song L; Qin Q; Wang Q; Shi M; Liu X
Thorac Cancer; 2018 Dec; 9(12):1687-1698. PubMed ID: 30267473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
